{
    "2018-05-29": [
        [
            {
                "time": "",
                "original_text": "全球首创乙肝治疗生物新药获批5只机构扎堆推荐股迎上涨机遇",
                "features": {
                    "keywords": [
                        "全球首创",
                        "乙肝",
                        "治疗",
                        "生物新药",
                        "机构推荐",
                        "上涨机遇"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报2018第20期:一致性评价、创新政策驱动医药长期向上",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "一致性评价",
                        "创新政策",
                        "长期向上"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}